Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less common cancers.
Following opening remarks from Jane Lyons, Chair, and David Fitzgerald, NHS England, attendees discussed three questions, covering risks and opportunities, integrated care and earlier diagnosis.
The discussion is summarised in this document.